Since, as mentioned above literature data showed overexpression of miR-155-5p in CLL and its important role in B cell lymphoproliferative disorders, we selected miR-155-5p as potential negative modulator of BTLA expression. The gene discussed is BTLA; the disease is B-cell chronic lymphocytic leukemia.